In: PATENT NEWS
Artificial intelligence (AI) is rapidly transforming the world of medicine, and the intellectual property directed to these inventions must keep pace. AI computers are diagnosing medical conditions and disorders at a rate equal to or better than their human peers, all while developing their own software code …
In: PATENT NEWS
Hailing from Bengaluru, 45-year-old Justice Yadav secured his law degree from the National Law School of India University in 1996 and he is a recipient of a gold medal in intellectual property law. He began practising law in 1997 and served as special counsel for State government in litigations related …
In: PATENT NEWS
Leaders in Law Finalists – Attorney Awards: INTELLECTUAL PROPERTY ATTORNEYS. Custom Content by the Los Angeles Business Journal. Wednesday, February 14, 2018 …
In: PATENT NEWS
She decided to invest $5,000 of her own money in Spanx, which was her entire life’s savings at the time. Since she couldn’t afford a lawyer to write her a patent, she did it on her own with the help of a text book on patent law from Barnes &... Continue reading
In: PATENT NEWS
Patently-O Authors. Dennis Crouch: Associate Professor, University of Missouri School of Law: SSRN Articles · Jason Rantanen: Professor, University of Iowa College of Law: SSRN Articles. Occasional guest posts by IP practitioners and academics …
In: PATENT NEWS
Patents for Real Estate Searching on a Computer Are Invalid Under Section 101 The National Law Review Full coverage
In: PATENT NEWS
RegeneRx Receives Canadian Patent for Treating Neurological Injury and Damage PR Newswire (press release) Full coverage
In: PATENT NEWS
Robotic Vision Awarded Robotic Automation Software Patents Photonics.com Full coverage
In: PATENT NEWS
Commentary on Patent Litigation Best Practices: International Trade Commission Section 337 Investigations Chapter Lexology Full coverage
In: PATENT NEWS
Law360 (February 13, 2018, 8:16 PM EST) — A split Ninth Circuit panel on Tuesday affirmed a jury decision in favor of EpiCept Corp. in a suit brought by doctors who claim the pharmaceutical company breached its contract by failing to develop patents into FDA-approved drugs, finding that the jury... Continue reading
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION